Sign inGet started

NEUP

Neuphoria Therapeutics Inc.CIK 1191070 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
6

AI insights for NEUP PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for NEUP
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Davies Peter Miles WinstonDirector2$0$02026-01-20
Wilson David IanDirector2$0$02026-01-20
Ryan JaneDirector2$0$02026-01-20
Fisher AlanDirector2$0$02026-01-20
Lynx1 Capital Management LP10% Owner1$3.29M$02025-10-21
Papapetropoulos SpyrosPresident and CEO3$0$02025-08-27

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Ryan JaneDirector A Award deriv2026-01-202026-01-218,537— $015,550SEC↗
Davies Peter Miles WinstonDirector A Award deriv2026-01-202026-01-218,537— $015,320SEC↗
Fisher AlanDirector A Award deriv2026-01-202026-01-2117,073— $030,731SEC↗
Wilson David IanDirector A Award deriv2026-01-202026-01-218,537— $015,412SEC↗
Lynx1 Capital Management LP10% Owner P Buy2025-10-212025-10-23639,110$5.14 $3.29M875,328SEC↗
Papapetropoulos SpyrosPresident and CEO A Award deriv2025-08-272025-09-0234,559$8.27 $285.8K74,088SEC↗
Fisher AlanDirector A Award deriv2025-04-162025-04-1813,566— $013,658SEC↗
Wilson David IanDirector A Award deriv2025-04-162025-04-186,783— $06,875SEC↗
Ryan JaneDirector A Award deriv2025-04-162025-04-186,783— $07,013SEC↗
Davies Peter Miles WinstonDirector A Award deriv2025-04-162025-04-186,783— $06,783SEC↗
Papapetropoulos SpyrosPresident and CEO A Award deriv2025-04-162025-04-18270,000$5.16 $1.39M282,529SEC↗
Papapetropoulos SpyrosPresident and CEO A Award deriv2025-04-162025-05-1927,000$5.16 $139.3K39,529SEC↗